Better Health Worldwide, Inc.
  • About
    • About Us
    • Blog
    • BH-WW in Action
  • Data & Analytics
    • Data Access, Analysis & Communications
    • Data Collection & Datasets
    • Disease Awareness
    • Market Research
  • Communications
    • Publications
    • Advisory Boards & Panels
    • Medical Science Liaisons
  • Contact
  • 📞 (973) 208-8621
Select Page

Prescription Medication Use Prior to and Following a Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD): Learnings from the Patient Journey

Mar 23, 2023

Specialty Pharmacy Products Used by Patients with Myotonic Dystrophy 2-Years Pre- and Post-Diagnosis

Mar 23, 2023

Myotonic Dystrophy, Comorbid Conditions and Healthcare Utilization Based on a 5-Year Comparative Real-World Data Analysis

Mar 23, 2023

The Cost of Suicide Attempts to Employers: Medical and Prescription Claims for Employees, Spouses, and Adult Dependents

Sep 13, 2022

Specialists involved in the diagnosis and management of myotonic dystrophy based on a real-world data analysis pre- and post-diagnosis

Sep 13, 2022

« Older Entries

Recent Posts

  • The Rarity of Rare Diseases
  • A Late Spring
  • Did the Meeting Really Happen?
  • Spring is in the Air—and what else?
  • Facebook
  • LinkedIn
©2022 Better Health Worldwide, All rights reserved.